Press Room

bonus 1a

Press Releases 2024

Bonus Biogroup is pleased to announce that on June 18, 2024, at the annual meeting of the International Society for Applied Biological Sciences (ISABS) [1], the Company disclosed that, pursuant to an outline agreed upon with the U.S. FDA, it has successfully completed the development of a unique quality control…
Bonus Biogroup is pleased to announce that on May 31, 2024, it presented at a special session [1] at the annual meeting of the International Society for Cell & Gene Therapy (ISCT) in Vancouver, Canada, the results of a Phase II clinical trial for treating facial bone deficiencies in the…
Bonus Biogroup is pleased to announce that it will present the final results of a Phase II clinical trial for treating facial bone deficiencies in the upper or lower jaw bones using BonoFill™—a live human bone graft manufactured by the Company (hereinafter: "Clinical Trial to Treat Facial Bone Deficiencies"). This…
Patents Granted in Europe and the UK, Following Earlier Approvals in the US, Australia, and China, Position the Company at the Forefront of Engineered Organ Development and Commercialization Bonus Biogroup is pleased to announce the approval of patents by the European and UK Patent Offices, covering 17 European countries and…
Bonus Biogroup Recognized as a Global Leader in Biotechnology and Cell Therapy at Advanced Therapies Week 2024 in Miami, USA Bonus Biogroup is proud to announce its remarkable achievement on January 18, 2024, having been awarded the prestigious Advanced Therapies Award in the foremost category: Cell Therapy Biotech Innovation [1].…
Bonus Biogroup is pleased to announce that the Japan Patent Office has granted a patent providing Bonus Therapeutics, a wholly-owned subsidiary of the Company, exclusive rights to use and commercialize cell characterization for transplantation [1]. These specialized cells are integral to "BonoFill," a living human bone graft developed by Bonus…

INFORMATION FOR INVESTORS  |  CAREER OPPORTUNITIES  |  INFORMATION FOR PATIENTS   |   RESEARCH COLLABORATIONS & BUSINESS DEVELOPMENT INQUIRIES

INFORMATION FOR INVESTORS

CAREER OPPORTUNITIES

INFORMATION FOR PATIENTS

RESEARCH COLLABORATIONS & BUSINESS DEVELOPMENT INQUIRIES

MAIL ICON  info@bonus-bio.com

MAIL ICON  +972 (0)73 206 7104

MAIL ICONMatam Advanced Technology
Park P.O.B 15143 Haifa 31905 Israel

you tube linkedin facebook twitter

© 2022 Bonus BioGroup Ltd. Created By Netron Israel Ltd

Please publish modules in offcanvas position.